Preliminary evaluation of in vitro cytotoxicity and in vivo antitumor activity of xanthium strumarium in transplantable tumors in mice

American Journal of Chinese Medicine

Volumn 41, Issue 1, 2013, Pages 145-162

  Aranjani, Jesil Mathew ^a   Manuel, Atulya ^a   Mallikarjuna Rao, Chamallamudi ^a   Udupa, Nayanabhirama ^a   Rao, Josyula Venkata ^a   Joy, Ann Mary ^b   Gandhi, Prajay ^b   Radhakrishnan, Ethiraj Kannat ^c  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

^b Biocon Park   (India)

^c VIT UNIVERSITY   (India)

Author keywords

DLA; EAC; MTT Assay; Solid Tumor; SRB Assay; Transplantable Tumors; Trypan Blue Dye Exclusion Assay; Xanthium strumarium

Indexed keywords

ANTINEOPLASTIC AGENT; CHLOROFORM; CISPLATIN; HEXANE; METHANOL; PLANT EXTRACT; SULFORHODAMINE B; TETRAZOLIUM; TRYPAN BLUE; UNCLASSIFIED DRUG; XANTHIUM STRUMARIUM EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASCITES TUMOR; BODY WEIGHT; CANCER INCIDENCE; CANCER INHIBITION; CARCINOGENESIS; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG SCREENING; FRUIT; HEMATOLOGICAL PARAMETERS; IC 50; IN VITRO STUDY; IN VIVO STUDY; LYMPHOMA CELL; MALE; MOUSE; NONHUMAN; PLANT LEAF; PLANT ROOT; PLANT STEM; TUMOR VOLUME; XANTHIUM;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, EHRLICH TUMOR; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; LYMPHOMA; MALE; MICE; NEOPLASM TRANSPLANTATION; PHYTOTHERAPY; PLANT EXTRACTS; XANTHIUM;

EID: 84873021246     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X13500110     Document Type: Article

References (32)

1. Aggarwal, B.B., M.E. Van Kuiken, L.H. Iyer, K.B. Harikumar and B. Sung. Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesis. Exp. Biol. Med. 234: 825-849, 2009
2. Ajith, T.A., K.B. Harikumar, H. Thasna, M.C. Sabu and N.V. Babitha. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice. Clin. Chim. Acta 366: 322-328, 2006
3. An, H.J., H.J. Jeong, E.H. Lee, Y.K. Kim, W.J. Hwang, S.J. Yoo, S.H. Hong and H.M. Kim. Xanthii fructus inhibits inflammatory responses in LPS-stimulated mouse peritoneal macrophages Inflammation 28: 263-270, 2004
4. Aranjani, J., C.M. Rao, A. Manuel, J.V. Rao, N. Udupa and K. Hebbar. Acute and subacute toxicity of chloroform and hexane extracts of root of Xanthium strumarium. Comp. Clin. Pathol :1223-1230, 2012
5. Berridge, M.V., P.M. Herst and A.S. Tan. Tetrazolium dyes as tools in cell biology: New insights into their cellular reduction. Biotechnol. Annu. Rev. 11: 127-152, 2005
6. Bisht, N. and R. Singh. Chemical constituents of the stem and roots of Xanthium strumarium L. J. Indian. Chem. Soc. 56: 108-109, 1979
7. Carmichael, J., W.G. DeGraff., A.F. Gazdar., J.D. Minna and J.B. Mitchell. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing Cancer Res. 47: 936, 1987
8. Gordaliza, M. Natural products as leads to anticancer drugs. Clin. Transl. Oncol. 9: 767-776, 2007
9. Jain, S.R. Investigations on antileucodermic activity of Xanthium strumarium. Planta Med. 16: 467-468, 1968
10. Jones, K.H. and J.A. Senft. An improved method to determine cell viability by simultaneous staining with fluorescein diacetate-propidium iodide. J. Histochem. Cytochem. 33: 77-79, 1985
11. Kamboj, A. and A. Saluja. Phytopharmacological review of Xanthium strumarium L. (Cocklebur). Int. J. Green. Pharm. 4: 129-139, 2010
12. Kim, I.T., Y.M. Park, J.H. Won, H.J. Jung, H.J. Park, J.W. Choi and K.T. Lee. Methanol extract of Xanthium strumarium L. possesses anti-inflammatory and anti-nociceptive activities. Biol Pharm. Bull. 28: 94-100, 2005
13. Kim, Y.S., J.S. Kim, S.H. Park, S.U. Choi, C.O. Lee, S.K. Kim, Y.K. Kim, S.H. Kim and S.Y. Ryu Two cytotoxic sesquiterpene lactones from the leaves of Xanthium strumarium and their in vitro inhibitory activity on farnesyltransferase. Planta Med. 69: 375-376, 2003
14. Kuo, Y.C., C.M. Sun, W.J. Tsai, J.C. Ou, W.P. Chen and C.Y. Lin. Chinese herbs as modulators of human mesangial cell proliferation: preliminary studies. J. Lab. Clin. Med. 132: 76-85, 1998
15. Kupiecki, F.P., C.D. Ogzewalla and F.M. Schell. Isolation and characterization of a hypoglycemic agent from Xanthium strumarium. J. Pharm. Sci. 63: 1166-1167, 1974
16. Maehara, Y., H. Anai, R. Tamada and K. Sugimachi. The ATP assay is more sensitive than the succinate dehydrogenase inhibition test for predicting cell viability. Eur. J. Can. Clin. Oncol 273-276, 1987
17. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55-63, 1983
18. Mukherjee, A.K., S. Basu, N. Sarkar and A.C. Ghosh. Advances in cancer therapy with plant based natural products. Curr. Med. Chem. 8: 1467-1486, 2001
19. Nobili, S., D. Lippi, E. Witort, M. Donnini, L. Bausi, E. Mini and S. Capaccioli. Natural compounds for cancer treatment and prevention. Pharmacol. Res. 59: 365-378, 2009
20. Price, V.E. and R.E. Greenfield. Anemia in cancer. Adv. Cancer Res. 5: 199-200, 1958
21. Rajesh, R., K. Chitra, P.M. Paarakh and N. Chidambaranathan. Anticancer activity of aerial parts of Aerva lanata Linn. Juss ex Schult against Dalton's Ascitic Lymphoma. Eur. J. Integr. Med. 3: 245-250, 2011
22. Ramirez-Erosa, I., Y. Huang, R.A. Hickie, R.G. Sutherland and B. Barl. Xanthatin and xanthinosin from the burs of Xanthium strumarium L. as potential anticancer agents. Can. J. Physiol Pharm. 85: 1160-1172, 2007
23. Rodriguez, E., G. Towers and J. Mitchell. Biological activities of sesquiterpene lactones. Phytochemistry 15: 1573-1580, 1976
24. Roussakis, C., I. Chinou, C. Vayas, C. Harvala and J. Verbist. Cytotoxic activity of xanthatin and the crude extracts of Xanthium strumarium. Planta Med. 60: 473-474, 1994
25. Skehan, P., R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J.T. Warren, H. Bokesch, S. Kenney and M.R. Boyd. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer I 82: 1107-1112, 1990
26. Slater, T., B. Sawyer and U. Sträuli. Studies on succinate-tetrazolium reductase systems. III. Points of coupling of four different tetrazolium salts. Biochim. Biophys. Acta 77: 383, 1963
27. Suffness, M. and J.M. Pezzuto. Assays related to cancer drug discovery. In: K. Hostettmann (ed.) Methods in Plant Biochemistry: Assays for Bioactivity. Academic Press, London, 1990, pp. 71-133
28. Talakal, T.S., S.K. Dwivedi and S.R. Sharma. In vitro and in vivo antitrypanosomal activity of Xanthium strumarium leaves. J. Ethnopharmacol. 49: 141-145, 1995
29. Vichai, V. and K. Kirtikara. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 1: 1112-1116, 2006
30. Vistica, D.T., P. Skehan, D. Scudiero, A. Monks, A. Pittman and M.R. Boyd. Tetrazolium-based assays for cellular viability: A critical examination of selected parameters affecting formazan production. Cancer Res. 51: 2515-2520, 1991
31. Voigt, W. Sulforhodamine B assay and chemosensitivity. Methods Mol. Med. 110: 39-48, 2005
32. Yamamoto, Y. and R.B. Gaynor. Therapeutic potential of inhibition of the NF-B pathway in the treatment of inflammation and cancer. J. Clin. Invest. 107: 135-142, 2001